下一个

自动播放

Exploring the Impact of Anti-PD-1 and Anti-PD-L1 Agents in Merkel Cell Carcinoma

3 意见 • 07/17/23
分享
嵌入
administrator
administrator
订户
0

Suzanne L. Topalian, MD, director, Melanoma Program, professor of Surgery, Johns Hopkins Medicine, discusses the impact of anti-PD-1 and anti-PD-L1 agents in the treatment of merkel cell carcinoma.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放